Disease Flare after Discontinuation of Crizotinib in Anaplastic Lymphoma Kinase-Positive Lung Cancer

Publisher： Karger

E-ISSN： 1662-6575|6|2|430-433

ISSN： 1662-6575

Source： Case Reports in Oncology, Vol.6, Iss.2, 2013-08, pp. : 430-433

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Case of Orbital Metastasis as Disease Progression of Anaplastic Lymphoma Kinase-Positive Lung Cancer Treated with Crizotinib

By  

Case Reports in Oncology, Vol. 8, Iss. 1, 2015-01 ,pp. : 21-24

Karger

Access to resources Recommend Favorite

Successful Management of Crizotinib-Induced Neutropenia in a Patient with Anaplastic Lymphoma Kinase-Positive Non-Small Cell Lung Cancer: A Case Report

By  

Case Reports in Oncology, Vol. 9, Iss. 1, 2016-01 ,pp. : 51-55

Karger

Access to resources Recommend Favorite

Successful Crizotinib Rechallenge after Crizotinib-Induced Organizing Pneumonia in Anaplastic Lymphoma Kinase-Rearranged Non-Small Cell Lung Cancer

By  

Case Reports in Oncology, Vol. 7, Iss. 3, 2014-09 ,pp. : 681-684

Karger

Access to resources Recommend Favorite

Alectinib-Induced Alopecia in a Patient with Anaplastic Lymphoma Kinase-Positive Non-Small Cell Lung Cancer

By  

Case Reports in Oncology, Vol. 9, Iss. 1, 2016-04 ,pp. : 212-215

Karger

Access to resources Recommend Favorite

Good Tolerance to Full-Dose Crizotinib in a Patient with Anaplastic Lymphoma Receptor Tyrosine Kinase-Rearranged Lung Adenocarcinoma and Preexisting Renal Impairment

By  

Case Reports in Oncology, Vol. 10, Iss. 2, 2017-05 ,pp. : 447-451

Karger

Access to resources Recommend Favorite